There are many obstacles to effective and proper access to health technologies (be them medicines, vaccines or diagnostic kits) high pricing being a major one; furthermore, lack of transparency of pharmaceutical markets and the disparity of prices offered from one country to another by pharmaceutical companies makes the bargaining process by State authorities much harder.
That´s why the second edition of MSF vaccine pricing report, released on January 20th is so valuable.We have included the accompanying text provided by MSF and uploaded the full report in the Reports sections. As usual, hyperlinks and background information from this blog, @OnadaExpansiva and other sources have been included at the end of the post.
That´s why the second edition of MSF vaccine pricing report, released on January 20th is so valuable.We have included the accompanying text provided by MSF and uploaded the full report in the Reports sections. As usual, hyperlinks and background information from this blog, @OnadaExpansiva and other sources have been included at the end of the post.
New MSF report reveals countries struggle with skyrocketing vaccine prices amidst market shrouded in secrecy
The Right Shot: Bringing Down Barriers to Affordable and AdaptedVaccines, shows that in the poorest countries, the price to vaccinate a
child is now a colossal 68 times more expensive than it was in 2001, with many
parts of the world unable to afford new high-priced vaccines like that against
pneumococcal disease, which kills about one million children each year.
